Studies in rats show ipamorelin increases tibial and vertebral BMC, primarily through bone growth and increased dimensions, while maintaining volumetric bone mineral density (BMD) (5)
The lipid content of thylakoid membranes is altered in plants that are exposed to HMs stress, which leads to membrane degradation and lipid peroxidation (Emamverdian et al., 2015)
Ultraviolet-B- and ozone-induced biochemical changes in antioxidant enzymes of Arabidopsis thaliana
HGH (Somatropin): FDA-approved for specific indications: pediatric growth hormone deficiency, adult GHD, Turner syndrome, HIV/AIDS-related wasting, short bowel syndrome Prescription-only medication requiring physician monitoring Illegal to distribute for off-label purposes including anti-aging (per the 1990 Anabolic Steroids Control Act amendments) Brand names include Genotropin, Norditropin, Humatrope, Saizen CJC-1295 and Ipamorelin: Neither is FDA-approved for any therapeutic indication Available as research compounds for laboratory use only (RUO Research Use Only) Not scheduled substances, but not approved for human therapeutic use Ipamorelin has undergone Phase I/II clinical trials (Johansen et al., 1999) but development did not progress to approval For a deeper look at Ipamorelin's regulatory history, see our Ipamorelin FDA approval status guide
Learn Myers' Cocktail, high-dose Vitamin C, glutathione, NAD+, B-vitamins, and hydration therapy protocols
